ENT Devices Market Overview
The ENT devices market is expected to reach USD 29.5 billion by 2030 to develop at CAGR of 6.2% over the gauge period 2022-2030.
ENT conditions are presently normal in the populace and include up to 20% of grown-ups and 40% of pediatric counsels and overall professionals. The most widely recognized ENT conditions are hearing misfortune, sinusitis, nasal polyps, vocal overlay loss of motion, muscle strain dysphonia,
Positive repayment for ENT methods and financing arrangements is one of the key elements driving the ENT gadgets market. For example, federal medical insurance public normal installment for Nasal/sinus endoscopy is USD 569, Adenoidectomy is USD 940, and Septoplasty or submucous resection is USD 940.
Different factors, for example, high predominance of persistent sinusitis, geriatric populace, mechanical progressions, developing reception of insignificantly intrusive ENT systems, and appeal for corrective ENT strategies are likewise expected to push the development of the market. Be that as it may, the significant expense of CO2 lasers and gadgets can hamper the market development over the figure time frame.
Mechanical progressions likewise assume a significant part in the growth of the market.
The European ENT gadgets market has been portioned into Western Europe and Eastern Europe. Western Europe has been delegated to Germany, France, the UK, Italy, Spain, and the remainder of Western Europe. The ENT gadgets market in Asia-Pacific has been divided into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The ENT gadgets market in the Middle East and Africa has been fragmented into the Middle East and Africa.
ENT Devices Market Segmentation
The ENT devices market is segmented based on product, end user, and region.
The Global market for ENT devices, by product is segmented into diagnostic devices, surgical devices, hearing aids, hearing implants, Co2 lasers, and image-guided surgery systems. The diagnostic devices segment is further classified as endoscopes and hearing screening devices. The endoscopes further segmented as rigid endoscopes and flexible endoscopes. The rigid endoscope segment includes otoscopes and sinuscopes. The flexible endoscope segment includes rhinoscopes, laryngoscopes, pharyngoscopes, and nasopharyngoscopes. The surgical devices segment is further classified as powered surgical instruments, radiofrequency (RF) handpieces, handheld instruments, balloon sinus dilation devices, ENT supplies, ear tubes, voice prosthesis devices. The handheld instrument segment includes rhinology instruments, otology instruments, laryngeal instruments, head and neck surgery instruments and others. The ENT supplies segment includes packing material, nasal stents & splints.
In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.
The ENT devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European ENT devices market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The ENT devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The ENT devices market in the Middle East & Africa has been segmented into the Middle East and Africa.
ENT Devices Market Regional Market Summary
Global ENT Devices market Share (%), by Region, 2017
Sources: MRFR Analysis
The Americas dominated the global market for ENT devices owing to the presence of major market players, increasing cases of hearing loss and developed economies like US and Canada within the region. As per the 2017 study published in The Hearing Journal, nearly 44 million U.S. adults over the age of 20 are expected to have hearing loss by 2020.
In 2017, it was estimated that Europe stood second in the ENT devices market. This can be attributed to the rising research and development investments and increasing technological advancements.
Asia Pacific was projected to be the fastest growing region in 2017. Increasing healthcare expenditure drives the regional markets of the Asia Pacific region. According to the data suggested by the Australian Institute of Health and Welfare, Australia spent nearly USD 181 billion on health in 2016–2017.
On the other hand, the Middle East and Africa held least share in the ENT devices market due to the low per capita income, especially within the African region.
Some of the key players in the ENT devices market are Atos Medical AB, Cochlear Limited, Hoya Corporation, Johnson & Johnson Services, Inc., Karl Storz Gmbh & Co. Kg, Medtronic PLC, Olympus Corporation, Rion Co. Ltd, Siemens Healthcare, Smith & Nephew PLC, Sonova Holding AG, Starkey Laboratories Inc., Stryker Corporation, Widex A/S, William Demant Holding A/S, and others.
Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.
Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the ENT devices. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.
The organization got CE Mark for Ambu scope 4 RhinoLaryngo Slim.
PENTAX Medical-a HOYA Group division, and Shanghai Aohua Photoelectricity Endoscope Co., Ltd. declared a joint venture to make items in flexible clinical endoscopy.
Market Segmentation and Key Market Players
ENT devices market, by Product
ENT devices market, by End User
|Market Size||USD 29.5 Billion : 2030|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product, End user, and Region|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Atos Medical AB, Cochlear Limited, Hoya Corporation, Johnson & Johnson Services, Inc., Karl Storz Gmbh & Co. Kg, Medtronic PLC, Olympus Corporation, Rion Co. Ltd, Siemens Healthcare, Smith & Nephew PLC, Sonova Holding AG, Starkey Laboratories Inc., Stryker Corporation, Widex A/S, William Demant Holding A/S, and others|
|Key Market Opportunities||Increasing cases of hearing loss and Developed economies|
|Key Market Drivers||
Cochlear Limited, Atos Medical AB, Hoya Corporation, Karl Storz Gmbh & Co. Kg, Johnson & Johnson Services, Inc., Medtronic PLC, Rion Co. Ltd, Olympus Corporation, Siemens Healthcare, Sonova Holding AG, Smith & Nephew PLC, Starkey Laboratories Inc., Widex A/S, Stryker Corporation, and William Demant Holding A/S, are some of the major players operating in the ENT devices market.
The global ENT devices market is projected to grow at approximately 6.2% CAGR during forecast period.
Favorable reimbursement for ENT procedures and funding policies.
North America holds the largest share in the global ENT devices market followed by Europe and Asia Pacific, respectively.
The outlook of the global ENT devices market looks very promising.